Skip to content

Protein expression analysis in pancreatic cancer specimens

Protein expression analysis after heavy ion radiotherapy in pancreatic cancer specimens - Heavy ion radiotherapy pancreatic cancer expression analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000054458
Enrollment
10
Registered
2024-05-27
Start date
2024-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

None listed

Sponsors

National Institutes for Quantum Science and Technology
Lead Sponsor
Dokkyo Medical University
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with remaining pathological tissue specimens removed during surgery from pancreatic cancer patients for whom surgery was indicated after heavy ion radiotherapy

Exclusion criteria

Exclusion criteria: Patients whose research subjects or their representatives have refused the use of pathological tissue specimens for this research

Design outcomes

Primary

MeasureTime frame
Expression pattern of target protein in pancreatic cancer specimens after heavy ion radiotherapy

Countries

Japan

Contacts

Public ContactAtsushi TSUJI

National Institutes for Quantum Science and Technology Department of Molecular Imaging and Theranostics, Institute for Quantum Medical Science

tsuji.atsushi@qst.go.jp043-382-3704

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026